Ubrogepant for the treatment of migraine attacks during the prodrome: a phase 3, multicentre, randomised, double-blind, placebo-controlled, crossover trial in the USA
暂无分享,去创建一个
L. Severt | D. Dodick | T. Schwedt | M. Finnegan | Peter J. Goadsby | Richard B. Lipton | Chengcheng Liu | Kaifeng Lu | S. Yu | Joel M. Trugman